Colorectal Cancer Market Research Reports

View More
TITLE Actions
Liquid Biopsy Market, by Cancer (Lung, Breast, Colorectal, etc), Products, Circulating Biomarkers, Sample, Clinical Application, Regions & Companies
Published in Jul 2018 | US $ 1990 Onwards | By Renub Research

Liquid Biopsy Market is projected to exceed US$ 3.4 Billion by the year 2024, witnessing the worldwide increasing prevalence of cancer and raising awareness regarding the minimal invasive liquid biopsy technology across the world. Today, liquid bi...

Global and Chinese In-vitro Colorectal Cancer Screening Tests Industry, 2018 Market Research Report
Published in Jul 2018 | US $ 3000 Onwards | By Prof Research

The 'Global and Chinese In-vitro Colorectal Cancer Screening Tests Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global In-vitro Colorectal Cancer Screening Tests industry with a focus on...

Global In-vitro Colorectal Cancer Screening Tests Market Size, Status and Forecast 2025
Published in Jul 2018 | US $ 3300 Onwards | By QYResearch Group

This report studies the global In-vitro Colorectal Cancer Screening Tests market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global In-vitro Colorectal Cancer Screening Tests ...

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018
Published in Jul 2018 | US $ 4000 Onwards | By GlobalData

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018" provides an ...

Colorectal Cancer - Pipeline Review, H1 2018
Published in Jun 2018 | US $ 2500 Onwards | By Global Markets Direct

Colorectal Cancer - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H1 2018, provides an overview of the Colorectal Ca...

Global Colorectal Cancer Partnering 2012 to 2018
Published in Apr 2018 | US $ 1995 Onwards | By Current Partnering

"Delivery of this report will take 1-3 days after purchase." Summary The Global Colorectal Cancer Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and a...

Colorectal Cancer (CRC) - Epidemiology Forecast to 2027
Published in Jan 2018 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Colorectal Cancer (CRC) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Colorectal Cancer (CRC) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016...

Colorectal Cancer (CRC) - Market Insight, Epidemiology and Market Forecast - 2027
Published in Jan 2018 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Colorectal Cancer (CRC) - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Colorectal Cancer (CRC) epidemiology and market outlook for the 7MM. Markets Covered -...

Cancer/Tumor Profiling Market by Application (Clinical, Research), Technology (Immunoassay, Hybridization (PCR, In Situ Hybridization, DNA/RNA Microarray), NGS, Mass Spectrometry), Cancer Type (Breast, Lung, Prostate, Colorectal) - Global Forecast to 2022
Published in Jan 2018 | US $ 5650 Onwards | By MarketsandMarkets

“The global cancer/tumor profiling market is projected to grow at a CAGR of 10.7%.” Global cancer/tumor profiling market is projected to reach USD 8.74 billion in 2022 from USD 5.26 billion in 2017 at CAGR of 1...

Colorectal Cancer - Pipeline Review, H2 2017
Published in Dec 2017 | US $ 2500 Onwards | By Global Markets Direct

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H2 2017, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is a cance...

Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017
Published in Dec 2017 | US $ 2500 Onwards | By GlobalData

Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, “Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Metastatic C...

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017
Published in Oct 2017 | US $ 4000 Onwards | By GlobalData

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides...

Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022
Published in Sep 2017 | US $ 5650 Onwards | By MarketsandMarkets

“Global liquid biopsy market projected to grow at a CAGR of 23.4%” The global liquid biopsy market is estimated to grow at a CAGR of 23.4% from 2017 to 2022, to reach USD 2,047.9 million by 2022. Increasing pre...

Colorectal Cancer Drug Development Pipeline Review, 2017
Published in Sep 2017 | US $ 3995 Onwards | By GBI Research

Colorectal Cancer Drug Development Pipeline Review, 2017 Summary Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal...

Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022
Published in Aug 2017 | US $ 5650 Onwards | By MarketsandMarkets

“Global companion diagnostics market projected to grow at CAGR of 20.1%” The global companion diagnostics market is projected to reach USD 6.51 billion by 2022 from USD 2.61 billion in 2017, at a CAGR of 20.1%....

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Published in Jul 2017 | US $ 4995 Onwards | By GBI Research

Summary Colorectal cancer (CRC) originates in either the colon or the rectum. It is one of the most common types of cancers, and is the third most common cancer among men and the second most common in women (ACS, 2017a; Fe...

Colorectal Cancer - Pipeline Review, H1 2017
Published in Jun 2017 | US $ 2500 Onwards | By Global Markets Direct

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H1 2017, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.Colon cancer is cancer that starts in the...

Colorectal Cancer - Heat Map and Analysis
Published in Feb 2017 | US $ 2000 Onwards | By GBI Research

Summary Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It ...

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025
Published in Jan 2017 | US $ 10995 Onwards | By GlobalData

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected to experience a...

Colorectal Cancer - Pipeline Review, H2 2016
Published in Dec 2016 | US $ 2500 Onwards | By Global Markets Direct

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.Colon cancer is cancer that starts in the...

We are on:

Need Help?